Safety and Immunogenicity of GSK2186877A in Elderly Subjects

• Research type

  Research Study

• Full title

  A phase III, observer-blind, multicountry, multicentre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals GSK2186877A influenza vaccine administered to adults aged 65 years and older compared to Fluarix™ administered to adults aged 18-41 years and 65 years and older, who previously participated in the 110847 study.

• IRAS ID

  6053

• Contact name

  Ravi Pawa

• Contact email

  ravi.pawa@synexus.com

• Sponsor organisation

  GlaxoSmithKline Biologicals Ltd

• Eudract number

  2008-002360-33

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  North East - Newcastle & North Tyneside 2 Research Ethics Committee

• REC reference

  08/H0907/112

• Date of REC Opinion

  9 Oct 2008

• REC opinion

  Further Information Favourable Opinion